| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.01 |